← All Posts
May 21, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: |
|
| 1.01 |
James S. Shannon, M.D., MRCP (UK) |
✓ For(23.931)
|
| 1.02 |
Michael E. Castagna, Pharm.D. |
Withhold(23.931)
|
| 1.03 |
Steven B. Binder |
Withhold(23.931)
|
| 1.04 |
Ronald J. Consiglio |
✓ For(23.931)
|
| 1.05 |
Michael A. Friedman, M.D. |
✓ For(23.931)
|
| 1.06 |
Jennifer Grancio |
✓ For(23.931)
|
| 1.07 |
Anthony Hooper |
✓ For(23.931)
|
| 1.08 |
Sabrina Kay, Ed.D. |
✓ For(23.931)
|
| 1.09 |
Christine Mundkur |
✓ For(23.931)
|
| 2 |
To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind's proxy statement for the Annual Meeting. |
✓ For(23.931)
|
| 3 |
To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2026. |
✓ For(23.931)
|
| 4 |
The transaction of such other business as may properly come before the meeting. |
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial